Alto Neuroscience (ANRO) Operating Leases (2024 - 2026)
Alto Neuroscience (ANRO) posted Operating Leases of $3.6 million for Q1 2026, down 7.01% sequentially from $3.8 million in Q4 2025, and down 19.41% YoY from $4.4 million in Q1 2025.
Alto Neuroscience (ANRO) Operating Leases (2024 - 2026) Analysis & Trends
Alto Neuroscience has reported Operating Leases for 3 years, with the latest figure at $3.6 million in Q1 2026.
- Quarterly Operating Leases fell 19.41% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 19.41% YoY) and the FY2025 annual result came in at $3.8 million, down 15.35% from the prior year.
- Operating Leases eased to $3.6 million in Q1 2026 per ANRO's latest filing, from $3.8 million in the prior quarter.
- Over five years, Operating Leases peaked at $5.2 million in Q3 2024 and troughed at $3.6 million in Q1 2026.
- A 3-year average of $4.2 million and a median of $4.2 million in 2025 frame the typical range for Operating Leases.
- The widest YoY moves for Operating Leases: up 15.35% in 2025, down 23.73% in 2025.
- Over 3 years, Operating Leases stood at $4.5 million in 2024, then slipped by 15.35% to $3.8 million in 2025, then declined by 7.01% to $3.6 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $3.6 million, $3.8 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alto Neuroscience | 1.13 Bn | 1.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.28 Mn |
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 3.82 Mn |
| Sep 30, 2025 | 3.97 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 4.52 Mn |
| Sep 30, 2024 | 5.20 Mn |